Sanaria

Recent papers from Sanaria

1. Pan-African hybridization of PfSPZ increases antigenic diversity and replicative capacity for malaria vaccine designJCI Insight · 2026
2. Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunityNature Communications · 2026
3. Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysisThe Lancet Microbe · 2026
4. Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trialNature Medicine · 2026
5. Successful insertion and expression of a tetracycline transactivator in Anopheles stephensi associated with increased egg production and decreased hatching rateParasites & Vectors · 2025
6. IgM, IgG, and IgG Subclass Antibody Responses to Plasmodium falciparum Proteins in Naïve, Malaria-Vaccinated and Semi-Immune Volunteers after Controlled Human Malaria InfectionAmerican Journal of Tropical Medicine and Hygiene · 2025
7. Complete attenuation of Plasmodium falciparum sporozoites by atovaquone–proguanilEMBO Molecular Medicine · 2025
8. Effect of controlled human Plasmodium falciparum infection on B cell subsets in individuals with different levels of malaria immunityMedical Microbiology and Immunology · 2025
9. Degradation of ribosomal RNA during Plasmodium falciparum gametocytogenesismBio · 2025
10. Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trialThe Lancet Infectious Diseases · 2025
11. Controlled human malaria infection with NF54 and 7G8 strains elicit differential antibody responses to Plasmodium falciparum peptidesFrontiers in Immunology · 2025
12. Manuscript title: Cytokines Associated With Moderate and Severe Adverse Events During a Sporozoite Malaria Vaccine Trial with Controlled Human Malaria Infection.2025
13. Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infectionMalaria Journal · 2025
14. Protective targets of PfSPZ vaccines identified from whole-genome sieve analysis of isolates from malaria vaccine efficacy trials in West Africa2025
15. High-Resolution Proteomics Unveils Salivary Gland Disruption and Saliva-Hemolymph Protein Exchange in Plasmodium -Infected Mosquitoes2025
16. Degradation of ribosomal RNA during Plasmodium falciparum gametocytogenesis2025
17. PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adultsEBioMedicine · 2024
18. Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adultsJournal of Infection · 2024
19. R21 malaria vaccine is protective against intradermal but not intravenousPlasmodium falciparumsporozoites in a randomized controlled human malaria infection study in Kenyan adults2024
20. Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptomsNature Communications · 2024